IDXX
NASDAQ
US
IDEXX Laboratories, Inc. - Common Stock
$569.55
▲ +$4.89
(+0.87%)
Vol 734K
11
Quality Score
ok
Deep Check
2/5
ok
Rev ✓
NI ✓
>IPO ✗
Mkt Cap
$54.0B
P/E
52.6
ROE
67.8%
Margin
24.7%
D/E
62.76
Beta
1.67
52W
$356–$770
Wall Street Consensus
22 analysts · Apr 20267
Strong Buy
9
Buy
6
Hold
0
Sell
0
Strong Sell
72.7%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 100.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $2.99 | $3.08 | +$0.09 |
| Sep 2025 | $3.19 | $3.40 | +$0.21 |
| Jun 2025 | $3.37 | $3.63 | +$0.26 |
| Mar 2025 | $2.91 | $2.96 | +$0.05 |
Quarterly Revenue & Earnings
| Quarter | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|
| Revenue | $954.3M | $998.4M | $1.1B | $1.1B | $1.1B |
| Net Income | $216.1M | $242.7M | $294.0M | $274.6M | $248.2M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 64.4% | 64.4% | 64.4% | 64.4% | 67.8% | 67.8% |
| P/E (TTM) | 43.76 | 51.66 | 48.97 | 51.10 | 57.24 | 52.58 |
| Net Margin | 26.5% | 24.4% | 24.4% | 24.4% | 24.6% | 24.6% |
| Gross Margin | 62.6% | 61.5% | 61.5% | 61.5% | 61.7% | 61.7% |
| D/E Ratio | 75.66 | 75.66 | 75.66 | 75.66 | 62.76 | 62.76 |
| Current Ratio | 1.11 | 1.11 | 1.11 | 1.11 | 1.18 | 1.18 |
Key Ratios
ROA (TTM)
31.1%
P/S (TTM)
12.96
P/B
21.2
EPS (TTM)
$12.61
CF/Share
$11.16
Rev Growth 3Y
+6.6%
52W High
$769.98
52W Low
$356.14
$356.14
52-Week Range
$769.98
Financial Health
Free Cash Flow
$326.1M
Net Debt
$796.0M
Cash
$180.1M
Total Debt
$976.1M
As of Dec 31, 2025
How does IDXX compare to Health Care peers?
Peer group: Micro-cap Health Care (All) · 241 companies
IDXX valuation vs Health Care peers
P/E ratio
52.6
▲
71%
above
peers
(30.7)
vs Peers
vs Industry
Undervalued
P/S ratio
13.0
▲
402%
above
peers
(2.6)
vs Peers
vs Industry
Overvalued
P/B ratio
21.2
▲
663%
above
peers
(2.8)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.7%)
vs Peers
vs Industry
Low yield
IDXX profitability vs Health Care peers
ROE
67.8%
▲
276%
above
peers
(-38.5%)
vs Peers
vs Industry
Top tier
Net margin
24.7%
▲
200%
above
peers
(-24.7%)
vs Peers
vs Industry
Top tier
Gross margin
61.7%
▲
17%
above
peers
(52.9%)
vs Peers
vs Industry
Below avg
ROA
31.1%
▲
246%
above
peers
(-21.2%)
vs Peers
vs Industry
Top tier
IDXX financial health vs Health Care peers
D/E ratio
62.8
▲
226%
above
peers
(19.3)
vs Peers
vs Industry
High debt
Current ratio
1.2
▼
45%
below
peers
(2.2)
vs Peers
vs Industry
Low liquidity
Beta
1.7
▲
59%
above
peers
(1.1)
vs Peers
vs Industry
More volatile
IDXX fundamentals radar
IDXX
Peer median
Industry
IDXX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
IDXX vs peers: key metrics
Related Signals
Latest AI Opinion
Grok
SKIP
Price action shows a prolonged downtrend from peaks above $750 in late 2025 to current levels around $558, with recent weekly closes declining from $636 (Mar 2) to $557 (Mar 30), indicating no clear reversal or upward momentum yet, making …
Apr 01, 2026